Scholars Central

Short communicationPublished 30 Jul 2021

Editorial Note on Gut Microbiota Diversity

Authors: Jennifer Chennat

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Acute myeloid leukemia (AML) in depth chemotherapy blended with broad-spectrum antibiotics ends in intestine microbiota dysbiosis selling pathological situations and an accelerated prevalence of complications. Here we file findings from a segment II single-arm, multicenter examine comparing autologous fecal microbiota transfer (AFMT) in 25 AML sufferers dealt with with in depth chemotherapy and antibiotics (ClinicalTrials.gov number: NCT02928523). The co-number one consequences of the examine are to assess the efficacy of AFMT in dysbiosis correction and multidrug-resistant Microorganism eradication.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Gastroenterology and Digestive Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastroenterology and Digestive Diseases
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Jennifer Chennat”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels